Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

NCT00183976 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00183976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00183976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2005
Completion date
January 31, 2006
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burkitt lymphoma, non-hodgkin's lymphoma, primary effusion lymphomas